This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11): e442.MathersCDLoncarD.Projections of global mortality and burden of disease from 2002 to 20302006311e44210.1371/journal.pmed.0030442Search in Google Scholar
Akesson A, Larsson SC, Discacciati A, Wolk A. Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: A population-based prospective cohort study. J Am Coll Cardiol. 2014; 64(13): 1299-1306.AkessonALarssonSCDiscacciatiAWolkA.Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: A population-based prospective cohort study201464131299130610.1016/j.jacc.2014.06.1190Search in Google Scholar
Strik JJ, Honig A, Maes M. Depression and myocardial infarction: Relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(4): 879-892.StrikJJHonigAMaesM.Depression and myocardial infarction: Relationship between heart and mind200125487989210.1016/S0278-5846(01)00150-6Search in Google Scholar
Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction – 2013. Curr Cardiol Rep. 2013; 15(6): 368.KesslerTErdmannJSchunkertH.Genetics of coronary artery disease and myocardial infarction – 2013201315636810.1007/s11886-013-0368-0Search in Google Scholar
Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009; 41(3): 280-282.SamaniNJErdmannJHallASHengstenbergCManginoMMayerBNew susceptibility locus for coronary artery disease on chromosome 3q22.3200941328028210.1038/ng.307Search in Google Scholar
Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015; 47(10): 1121-1130.NikpayMGoelAWonHHHallLMWillenborgCKanoniSA comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease201547101121113010.1038/ng.3396Search in Google Scholar
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2): 309-319.SimonetWSLaceyDLDunstanCRKelleyMChangMSLüthyROsteoprotegerin: A novel secreted protein involved in the regulation of bone density199789230931910.1016/S0092-8674(00)80209-3Search in Google Scholar
Montagnana M, Lippi G, Danese E, Guidi GC. The role of osteoprotegerin in cardiovascular disease. Ann Med. 2013; 45(3): 254-264.MontagnanaMLippiGDaneseEGuidiGC.The role of osteoprotegerin in cardiovascular disease201345325426410.3109/07853890.2012.72701923110639Search in Google Scholar
Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis. 2009; 204(2): 321-329.Van CampenhoutAGolledgeJ.Osteoprotegerin, vascular calcification and atherosclerosis2009204232132910.1016/j.atherosclerosis.2008.09.033272905219007931Search in Google Scholar
Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation. 2002; 106(10): 1192-1194.JonoSIkariYShioiAMoriKMikiTHaraKSerum osteoprotegerin levels are associated with the presence and severity of coronary artery disease2002106101192119410.1161/01.CIR.0000031524.49139.2912208791Search in Google Scholar
Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab. 2003; 88(3): 1024-1028.SchoppetMSattlerAMSchaeferJRHerzumMMaischBHofbauerLC.Increased osteoprotegerin serum levels in men with coronary artery disease20038831024102810.1210/jc.2002-02077512629080Search in Google Scholar
Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC et al. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab. 2004; 89(8): 3764-3768.SoufiMSchoppetMSattlerAMHerzumMMaischBHofbauerLCOsteoprotegerin gene polymorphisms in men with coronary artery disease20048983764376810.1210/jc.2003-03205415292302Search in Google Scholar
Ohmori R, Momiyama Y, Taniguchi H, Tanaka N, Kato R, Nakamura H, et al. Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. Atherosclerosis. 2006; 187(1): 215-217.OhmoriRMomiyamaYTaniguchiHTanakaNKatoRNakamuraHAssociation between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men2006187121521710.1016/j.atherosclerosis.2006.03.02616678184Search in Google Scholar
Luo ZR, Xie QJ. Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue. 2012; 24(12): 730-733.LuoZRXieQJ.Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area20122412730733Search in Google Scholar
Celczyńska Bajew L, Horst Sikorska W, Bychowiec B, Wykrętowicz A, Wesoly J, Michalak M. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. Kardiol Pol. 2011; 69(6): 573-578.Celczyńska BajewLHorst SikorskaWBychowiecBWykrętowiczAWesolyJMichalakM.The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density2011696573578Search in Google Scholar
Hong WL, Guo XG, Jiao QP, Tan ZR, Chen Y, Qiu ZH, et al. Correlation of osteoprotegerin gene G1181C polymorphisms with presence and severity of coronary artery disease in Chinese Han people in Shanghai. Shanghai Med J. 2012; 35(5): 420-424.HongWLGuoXGJiaoQPTanZRChenYQiuZHCorrelation of osteoprotegerin gene G1181C polymorphisms with presence and severity of coronary artery disease in Chinese Han people in Shanghai2012355420424Search in Google Scholar
Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994; 90(1): 583-612.Tunstall-PedoeHKuulasmaaKAmouyelPArveilerDRajakangasAMPajakA.Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents199490158361210.1161/01.CIR.90.1.5838026046Search in Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603-605.StangA.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses201025960360510.1007/s10654-010-9491-z20652370Search in Google Scholar
Guo C, Hu F, Zhang S, Wang Y, Liu H. Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients. Genet Mol Biol. 2013; 36(2): 177-182.GuoCHuFZhangSWangYLiuH.Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients201336217718210.1590/S1415-47572013005000024371528223885198Search in Google Scholar
Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol. 2010; 55(19): 2049-2061.VenurajuSMYerramasuACorderRLahiriA.Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity201055192049206110.1016/j.jacc.2010.03.01320447527Search in Google Scholar
Ren MY, Sui SJ, Zhang Y, Xu FY, Xu XQ, Zhao JJ, et al. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome. Acta Cardiol. 2008; 63(5): 615-622.RenMYSuiSJZhangYXuFYXuXQZhaoJJIncreased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome200863561562210.2143/AC.63.5.203323019014006Search in Google Scholar